Larvol Delta - 4D-pharma-Reports-Full-Year-2021-Financial-Results-Operational-Highlights-and-Guidance-for-Key-Milestones-in-2022

MRx0029 - 4D Pharma

MRx0005 - 4D Pharma

https://www.businesswire.com/news/home/20220331006021/en/4D-pharma-Reports-Full-Year-2021-Financial-Results-Operational-Highlights-and-Guidance-for-Key-Milestones-in-2022

Mar 31, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next